Business Context and Reporting Period
This Form 6-K filing by Medirom Healthcare Technologies Inc. (a Japanese foreign private issuer) is dated April 23, 2025, covering the month of April 2025. The report serves to notify shareholders of the convocation of the 25th Ordinary General Meeting of Shareholders for Fiscal Year 2024, scheduled to be held in Tokyo, Japan, on May 30, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding shareholder meeting logistics and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are disclosed in this filing, as the document focuses solely on the administrative notification of the upcoming shareholder meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It explicitly states that the report does not constitute a proxy solicitation and directs shareholders to the attached proxy materials (Exhibits 99.1, 99.2, and 99.3) for voting instructions.
Key Facts for Investor Verification
- The 25th Ordinary General Meeting of Shareholders is scheduled for May 30, 2025, in Tokyo, Japan.
- Proxy materials and voting instructions for both common shares and American Depositary Shares (ADS) were circulated on April 18, 2025.
- Shareholders must refer to the specific proxy cards (Japanese Card or ADS Card) included as exhibits to vote or attend the meeting.
- This Form 6-K does not contain financial results for Fiscal Year 2024; investors should review the Company's Form 20-F or other financial reports for performance data.